Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 11 hours agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 month agoUnited Therapeutics Corp showcases robust revenue growth and solid operational performance....
Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair
Zacks via Yahoo Finance· 3 months agoMerck MRK announced that the FDA has granted approval to its novel activin signaling inhibitor,...
Is Merck Moving Toward Another Blockbuster Drug Launch?
Motley Fool· 2 years agoEarlier this month, Merck (NYSE: MRK) announced that in a phase 3 clinical trial its drug candidate,...
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Zacks via Yahoo Finance· 3 months agoWhile AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior...
Medications for Pulmonary Arterial Hypertension
Verywell Health via Yahoo News· 8 months agoLearn about the medications used to treat pulmonary arterial hypertension (PAH), a specific type of PH characterized by hypertension (high blood...
J&J (JNJ) Submits NDA for Single Tablet Combo to Treat PAH
Zacks via Yahoo Finance· 1 year agoJ&J (JNJ) submits a new drug application for a single tablet combination therapy of macitentan and...
Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept
Zacks via Yahoo Finance· 1 year agoMerck & Co. (MRK) announces detailed data from the phase III STELLAR study of sotatercept for the...
Merck (MRK) Posts Positive Results From PAH Drug Study
Zacks via Yahoo Finance· 2 years agoMerck's (MRK) sotatercept meets primary and secondary endpoints in a phase III study in pulmonary...
FDA Accepts Merck's (MRK) Filing for Sotatercept in PAH Disease
Zacks via Yahoo Finance· 8 months agoThe FDA grants priority review to Merck's (MRK) FDA filing for sotatercept to treat adults with...